LaylaBird/E+ via Getty Images
Quick Take
Cytek Biosciences (CTKB) has filed to raise $248 million in an IPO of its common stock, according to an S-1/A registration statement.
The firm provides cell analysis instruments to biomedical researchers and clinical…
Cytek Biosciences Proposes Terms For $248 Million IPO
Share this article
More News
Stalled Twice at $750, Is the Rally Over?
September 23, 2026
Why Mastercard’s $25 billion crypto expansion isn’t what it seems
September 23, 2026
